SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
3.955
-0.095 (-2.35%)
Jul 22, 2026, 4:00 PM EDT - Market closed
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $39.27 million as of July 23, 2026. Its market cap has increased by 41.46% in one year.
Market Cap
39.27M
Enterprise Value
-17.93M
1-Year Change
41.46%
Ranking
Category
Stock Price
$3.96
ChartMarket Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.07M to $39.27M, a decrease of -48.37%. That is a compound annual growth rate of -5.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 39.27M | 47.99% |
| Dec 31, 2025 | 26.54M | -42.20% |
| Dec 31, 2024 | 45.92M | -44.66% |
| Dec 29, 2023 | 82.97M | 62.87% |
| Dec 30, 2022 | 50.94M | -70.72% |
| Dec 31, 2021 | 173.97M | 17.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 115.19M |
| China SXT Pharmaceuticals | 86.34M |
| Talphera | 67.99M |
| Citius Oncology | 53.00M |
| InterCure | 50.64M |
| Incannex Healthcare | 38.41M |
| BioXcel Therapeutics | 27.72M |
| Optimi Health | 26.93M |